April 27, 2007 — Mobile Aspects, a provider of RFID-enabled solutions to improve medical device and supply management for hospitals, has received a patent for its iRISupply clinical resource management solution.

Implemented in clinical areas such as interventional cardiology, interventional radiology, and surgical specialties such as cardiovascular surgery and endovascular surgery, the cabinet-based iRISupply system enables the provision of real-time information to effectively store, track, and manage the high-cost inventories used in surgical procedures.

April 27, 2007 — Cardiac Science Corp. announced Thursday it has reached a settlement in its long-standing patent litigation with Philips. Under the settlement agreement, all claims by each side have been dismissed, and each side has been granted rights to the respective defibrillation technology patents of the other side that were a part of the suit.

In addition, Cardiac Science has been granted a perpetual, royalty-free, worldwide license to certain other defibrillation patents of Philips not associated with the suit in exchange for a one-time payment of $1 million.

April 27, 2007 — Berlin-based BIOTRONIK announced today that is launching a worldwide long-term clinical study to investigate the effectiveness of ablation therapy in patients suffering from atrial fibrillation and congestive heart failure. The CASTLE-AF Study (Catheter Ablation versus Conventional Treatment in Patients with Left Ventricular Dysfunction and Atrial Fibrillation) will compare the clinical effect of ablation therapy to the conventional therapy for atrial fibrillation regarding the treated patient's life expectancy and hospitalization.

April 26, 2007 — ZOLL Medical Corp., manufacturer of resuscitation devices and related software solutions, announced today the release of a new model of the ZOLL AutoPulse Non-Invasive Cardiac Support Pump, which can document, store and upload device and patient data.

The new capability allows uploading of information from as many as four patients to ZOLL RescueNet Code Review or CodeNet software via an infrared communications port on the AutoPulse.

April 26, 2007 — Angiotech Pharmaceuticals Inc., a global specialty pharmaceutical and medical device company, has announced that the two-year data from its European pivotal trial examining the Vascular Wrap Paclitaxel-Eluting Mesh (Vascular Wrap) is being presented today at a scientific forum in Europe.

April 26, 2007 — Bristol-Myers Squibb Co. and Pfizer Inc. have announced a worldwide collaboration to develop and commercialize apixaban, an anticoagulant discovered by Bristol-Myers Squibb that is being studied for the prevention and treatment of a broad range of venous and arterial thrombotic conditions.

April 26, 2007 — Cardiologist Lee A. Surkin, M.D., FAAC, is set to launch a new line of cardiac nutritional supplements this July. He says the new Cardiac Wellness Supplements are designed to complement, not replace, standard cardiovascular disease prevention and treatment therapies.

April 26, 2007 — Northwest Center for Congenital Heart Disease has announced the establishment of an imaging network to improve cardiac services provided to patients throughout the Inland Northwest. The new network enables the transmission of an echocardiogram, a moving ultrasound image of the heart, through a secure Internet site from a hospital to an office/home computer.

April 26, 2007 — Skyscape, a provider of trusted medical information by specialty for mobile devices, has announced its launch of MedStream 360, to deliver medical information by specialty to physicians' mobile devices.

The new MedStream 360 is a critical component of the Skyscape STAT service that seamlessly integrates dynamic up-to-the-minute content with its portfolio of over 450 trusted resources.

April 25, 2007 — Bristol-Myers Squibb will host a groundbreaking ceremony May 2 for its new biologics facility in Devens, MA. The state’s governor, Deval Patrick, as well as other state and local officials and community leaders will be present. Speakers at the groundbreaking will include Gov. Patrick and Bristol-Myers Squibb chief executive officer Jim Cornelius.

The company announced the selection of the Devens site in June 2006 and recently began construction of the facility, which is expected to be operational in 2009.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now